Galera therapeutics announces interim data from pilot phase 1/2 trial of gc4419 in combination with stereotactic body radiation therapy showed improved overall survival in patients with locally advanced pancreatic cancer

Initial results from pilot phase 1/2 clinical trial in patients with locally advanced pancreatic cancer presented during virtual astro annual meeting

GRTX Ratings Summary

GRTX Quant Ranking